Omniflow II is promoted as an infection-resistant vascular graft. It is used to treat vascular graft infection; nevertheless, early graft infection has been reported.
Report: A 71-year-old patient was treated with an Omniflow II bypass for a non-healing diabetic foot ulcer. Seven months postoperatively, late infection occurred secondary to hematogenous spread from a persistent foot infection.
Conclusion
We report on the first case of late infection of an Omniflow II vascular graft caused by hematogenous spread. Despite promising results of the Omniflow II graft in the treatment of vascular graft infection, late infection may not be avoided.
BetzTNeuwerthDSteinbauerM, et al.Biosynthetic vascular graft: a valuable alternative to traditional replacement materials for treatment of prosthetic aortic graft infection?Scand J Surg2019; 108: 291–296.
2.
WiltbergerGMatiaISchmelzleM, et al.Mid- and long-term results after replacement of infected peripheral vascular prosthetic grafts with biosynthetic collagen prosthesis. J Cardiovasc Surg2014; 55: 693–698.
3.
NeufangADuenschedeFEspinola-KleinC, et al.Contemporary results with the biosynthetic glutaraldehyde denatured ovine collagen graft (Omniflow II) in femoropopliteal position. J Vasc Surg2020; 71: 1630–1643.
4.
DunschedeFYoussefMStabrauskaiteJ, et al.Omniflow-II(TM) for critical limb ischemia: long-term results. Chirurg2017; 88: 233–238.
5.
NeufangADorweilerBEspinola-KleinC, et al.Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg2014; 60: 1543–1553.
6.
WilsonWRBowerTCCreagerMA, et al.Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation2016; 134: e412–e460.
7.
ChaudharyRSimmonsRL.Pathogenesis of vascular graft infections. J Vasc Surg1991; 13: 755–756.
8.
DunschedeFStabrauskaiteJWeisserG, et al.Crural bypass for critical lower limb ischemia with omniflow II prosthesis. Thorac Cardiovasc Surg2016; 64: 311–315.
9.
KochGGutschiSPascherO, et al.Analysis of 274 omniflow vascular prostheses implanted over an eight-year period. Aust N Z J Surg1997; 67: 637–639.
10.
TopelIStiglerTAyxI, et al.Biosynthetic grafts to replace infected prosthetic vascular bypasses: a single-center experience. Surg Infect2017; 18: 202–205.
